The New Patient Visit
Maribel Gonzalez, MS, ARNP, FNP-C

Using patient cases, the speaker will describe the necessary components of an initial patient visit, including full history, physical exam, baseline laboratory studies, and other screenings. Follow-up laboratory and other screenings as recommended by the Department of Health and Human Services and other pertinent guidelines will be discussed. The speaker will also address important components of patient education and counseling including HIV prevention.
(Handouts/PDF)
(Slides/PPT)

Overview of OI Prevention and Treatment
Patricia Gilliam, PhD, MEd, NP, AAHIVS

Prevention and early diagnosis of opportunistic infections (OIs) is crucial in minimizing the complications and improving outcomes in the HIV-infected patients. The speaker will provide a summary of the indications and recommended treatment regimens for primary and secondary prevention of OIs and required vaccinations for HIV-infected patients.  Case presentations will be used to teach the clinician how to recognize the symptoms, what diagnostic studies to order, and how to choose appropriate treatment regimen for the most common OIs. The speaker will also highlight the available resources including the Opportunistic Infection Pocket Card developed by Florida/Caribbean AETC.
(Handouts/PDF)

Managing the ARV-Naïve Patient
Ernesto J. Lamadrid, MD, AAHIVS

The speaker will discuss regimens recommended for treatment-naïve patients according to the most recent Department of Health and Human Services guidelines. Using patient cases, the speaker will describe the factors that need to be considered when designing the first regimen, including co-morbid conditions, and concomitant medications.
(Handouts/PDF)
(Slides/PPT)

Women's Issues
Jennifer Janelle, MD

During this session, the speaker will discuss matters of particular importance to women infected with HIV including, cervical cancer screening, contraception modalities, and reproduction issues.
(Handouts/PDF)
(Slides/PPT)

TB in HIV
David Ashkin, MD, FCCP

Tuberculosis remains a leading cause of death among HIV-infected patients worldwide. Annual screening for latent TB infection remains an important recommended prevention strategy in HIV-infected individuals. Diagnosing and treating active tuberculosis in HIV-infected individuals can be challenging due to the often atypical presentation and drug-drug interactions among anti-TB and HIV therapies. This session will utilize cases to review screening and treatment of latent TB infection, clinical presentation of active TB disease, and treatment of active TB.
(Handouts/PDF)
(Slides/PPT)

Complications of Antiretroviral Therapy
Sandy J. Estrada, PharmD, BCPS

The speaker will discuss the most common and most severe potential complications of antiretroviral therapy.  Patient cases will be used to demonstrate potential complications of therapy and how to promptly recognize, manage, and/or prevent adverse events from therapy.
(Handouts/PDF)
(Slides/PPT)

Motivating Patients to Make Change
Ann Landes, PhD

The speaker will describe motivational interviewing techniques that can be utilized to encourage patients with HIV to make important lifestyle and behavioral modifications to improve overall health. These changes may be aimed at a variety of desired outcomes including adherence to antiretroviral therapy, cessation of drugs, alcohol, or tobacco use, and risk reduction.
(Handouts/PDF)
(Slides/PPT)

STD Treatment Guidelines Update
John Toney, MD, FACP, FIDSA

A series of case presentations will be used to illustrate the diagnosis and treatment of the most commonly encountered STD infections in HIV patients. The speaker will review the newest treatment guidelines of STD infections and describe the resources available to assist the clinician with management of STD infections in immunocompromised patients.
(Handouts/PDF)
(Slides/PPT)

Resistance Testing Fundamentals
Todd S. Wills, MD

Different mechanisms of resistance patterns, as well as the specific role the therapeutic agents play while attacking the virus during different stages of the viral replication cycle, will be discussed. This interactive session will also demonstrate how to interpret resistance tests of patients with simple and complex resistance patterns. Indications for ordering genotypes, virtual phenotypes, and phenotypes will be reviewed.
(Handouts/PDF)
(Slides/PPT)

Antiretroviral Drug Interactions
Joanne J. Orrick, PharmD, AAHIVE

Antiretroviral drug interactions contribute to the complexity of managing HIV-infected patients.  The speaker will review the mechanisms of drug-drug interactions and discuss the most common and/or significant drug-drug interactions involving antiretroviral therapy.  The participant will be provided resources to assist in the assessment and management of drug-drug interactions.
(Handouts/PDF)
(Slides/PPT)

Hepatitis B and C Co-infection
Dushyantha Jayaweera, MD, MRCOG (UK), FACP

Hepatitis B and C co-infection in the HIV-infected patient results in significant increase in cost, as well as earlier morbidity and mortality. This session will review the indications for treatment of the co-infected patient including: making the decision when to treat, selecting the treatment regimens, managing the complications and side effects, as well as monitoring the patients who fail therapy. New therapeutic options will be discussed as well as selection criteria for transplant eligibility.
(Handouts/PDF)
(Slides/PPT)